Physician profile
Jonathan Mckeeman
NPI 1487386934
$6,137.62
in general payments reported to CMS, 2019-2025
14 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,864 · 2023: $910 · 2024: $1,729 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,865 · Travel and Lodging: $732 · Education: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,865.20 |
| Travel and Lodging | $731.54 |
| Education | $676.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,819.24 | 2022-2025 | Mako, Infinity, Hoffmann |
| Novus Surgical Solutions LLC | $1,317.38 | 2022 | |
| Medical Device Business Services, INC. | $1,035.96 | 2022-2025 | Actis, Na |
| Globus Medical, INC. | $547.04 | 2024 | Autobahn |
| Novus Surgical Consultants | $484.44 | 2022-2025 | |
| Medtronic, INC. | $228.47 | 2023-2025 | Prestige LP Cervical Disc System |
| Depuy Synthes Sales INC. | $167.08 | 2023-2024 | Na, Motoband, Va-Lcp |
| Arthrex, INC. | $164.54 | 2025 | |
| Axogen | $143.79 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Cerapedics INC. | $72.50 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medline Industries LP | $57.71 | 2023 | |
| Sanara Medtech INC. | $42.26 | 2024 | Celleraterx |
| Solventum Corporation | $29.04 | 2024-2025 | Prevena, Activ.A.C., V.A.C.Ulta |
| Abbvie INC. | $28.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mckeeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.